€ 0
Overview
| Donor: | Gilead |
| Application procedure: | Online Application |
| Donor base: | United States |
| Reference number: | - |
| Eligible applicants: | Non-Profit Organisation |
| Deadline: | ongoing |
Financial details
| Grant size: | Medium - up to $1,000,000 |
| Minimum grant size: | - |
| Total available budget: | - |
| Funding type: | Grants |
| Maximum grant size: | - |
| Funding ratio: | up to 100% |
Sectors
- Capacity Building
- Education
- Health
- Research, Technology & Innovation
- Social Inclusion
Project Locations
Africa
Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Democratic Republic of the Congo, Djibouti, Egypt, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea Bissau, Ivory Coast, Kenya, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Mauritius, Morocco, Mozambique, Namibia, Niger, Nigeria, Republic of the Congo, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tanzania, Togo, Tunisia, Uganda, Western Sahara, Zambia, Zimbabwe
America
Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominica, Dominican Republic, Ecuador, El Salvador, French Guiana, Grenada, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago, Uruguay, Venezuela
Asia
Afghanistan, Azerbaijan, Bahrain, Bangladesh, Bhutan, Brunei, Cambodia, China, East Timor, India, Indonesia, Iran, Iraq, Israel, Japan, Jordan, Kazakhstan, Korea, Kuwait, Kyrgyzstan, Laos, Lebanon, Malaysia, Maldives, Mongolia, Myanmar, Nepal, North Korea, Oman, Pakistan, Palestine, Philippines, Qatar, Russian Federation, Saudi Arabia, Singapore, South Korea, Sri Lanka, Syria, Taiwan, Tajikistan, Thailand, Turkey, Turkmenistan, United Arab Emirates, Uzbekistan, Vietnam, West Bank and Gaza, Yemen
Europe
Albania, Armenia, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Georgia, Hungary, Kosovo, Latvia, Lithuania, Moldova, Montenegro, North Macedonia, Poland, Romania, Serbia, Slovakia, Slovenia, Ukraine
Pacific
Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu
Description
1) Objective
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. They strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead welcomes funding requests for innovative, high impact projects that relate to at least one of our core therapeutic areas:
- HIV
- Liver disease: HCV, HBV, HDV
- Oncology: Hematology, Solid tumors
- Inflammatory and respiratory disease
Abroad, they also fund projects that (1) improve access to healthcare; (2) reduce disparities for disadvantaged groups; (3) educate among patients and healthcare professionals; and (4) support local communities.
2) Eligibility
They work with patient advocates, nonprofits, and healthcare professionals across all our therapeutic areas of focus to improve care through partnerships and community engagement. Only tax exempt nonprofits are eligible.
3) Location
Actions can take place worldwide.
4) Budget
Gilead does not place a limit on how much grantees can apply for.
5) Application
To apply for financial support under Gilead’s Corporate Giving program, applicants are required to visit the U.S. Corporate Grants and Giving page as application procedures and eligibility vary according to location. Grant applications are accepted throughout the year. Funding requests must be submitted a minimum of eight weeks prior to the start of the activity. The typical grant review timeline can be up to 12 weeks. Formal notifications of all funding decisions are sent in writing by email to the contact listed on the grant application. Before applying, applicants must carefully review the funding priorities, terms and conditions and frequently asked questions as well as eligible countries.